The upregulation of CCNB1, CDK1, CXCL8, IGFBP3, MYBL2, SERPINE1 also notably indicated poor overall survival of glioma patients (HR>1, P=0.000<0.05). This evidence concerns the gene CDK1 and central nervous system cancer.